
Transmedics Group Inc
NASDAQ:TMDX

Income Statement
Earnings Waterfall
Transmedics Group Inc
Revenue
|
441.5m
USD
|
Cost of Revenue
|
-179.5m
USD
|
Gross Profit
|
262.1m
USD
|
Operating Expenses
|
-224.6m
USD
|
Operating Income
|
37.5m
USD
|
Other Expenses
|
-2m
USD
|
Net Income
|
35.5m
USD
|
Income Statement
Transmedics Group Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
8
N/A
|
9
+14%
|
9
+8%
|
12
+23%
|
13
+12%
|
15
+17%
|
18
+18%
|
21
+18%
|
24
+12%
|
26
+12%
|
24
-9%
|
24
0%
|
26
+7%
|
25
-2%
|
30
+19%
|
28
-6%
|
30
+7%
|
39
+29%
|
51
+32%
|
72
+39%
|
93
+30%
|
119
+27%
|
151
+27%
|
192
+27%
|
242
+26%
|
297
+23%
|
359
+21%
|
401
+12%
|
442
+10%
|
|
Gross Profit | ||||||||||||||||||||||||||||||
Cost of Revenue |
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(9)
|
(9)
|
(11)
|
(14)
|
(20)
|
(28)
|
(37)
|
(47)
|
(65)
|
(88)
|
(112)
|
(141)
|
(163)
|
(179)
|
|
Gross Profit |
2
N/A
|
3
+29%
|
3
+13%
|
5
+53%
|
6
+20%
|
7
+29%
|
10
+29%
|
12
+22%
|
14
+19%
|
16
+17%
|
15
-9%
|
16
+6%
|
17
+7%
|
17
0%
|
20
+22%
|
19
-6%
|
21
+11%
|
28
+34%
|
37
+31%
|
52
+39%
|
65
+27%
|
82
+26%
|
104
+27%
|
127
+22%
|
154
+21%
|
185
+20%
|
218
+18%
|
238
+9%
|
262
+10%
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(23)
|
(22)
|
(22)
|
(23)
|
(26)
|
(29)
|
(34)
|
(39)
|
(43)
|
(48)
|
(47)
|
(45)
|
(43)
|
(41)
|
(47)
|
(53)
|
(61)
|
(71)
|
(79)
|
(88)
|
(97)
|
(107)
|
(120)
|
(163)
|
(154)
|
(200)
|
(219)
|
(207)
|
(225)
|
|
Selling, General & Administrative |
(8)
|
(8)
|
(9)
|
(10)
|
(12)
|
(15)
|
(18)
|
(22)
|
(24)
|
(26)
|
(25)
|
(24)
|
(24)
|
(24)
|
(28)
|
(32)
|
(38)
|
(45)
|
(54)
|
(60)
|
(70)
|
(81)
|
(93)
|
(105)
|
(117)
|
(129)
|
(142)
|
(156)
|
(168)
|
|
Research & Development |
(15)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(17)
|
(20)
|
(22)
|
(21)
|
(21)
|
(19)
|
(17)
|
(20)
|
(21)
|
(22)
|
(25)
|
(26)
|
(27)
|
(27)
|
(25)
|
(27)
|
(58)
|
(36)
|
(69)
|
(74)
|
(50)
|
(56)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
|
Operating Income |
(20)
N/A
|
(20)
+3%
|
(19)
+3%
|
(18)
+4%
|
(20)
-10%
|
(21)
-6%
|
(24)
-12%
|
(27)
-14%
|
(30)
-9%
|
(32)
-7%
|
(32)
0%
|
(29)
+8%
|
(26)
+10%
|
(25)
+6%
|
(27)
-8%
|
(34)
-26%
|
(39)
-16%
|
(42)
-7%
|
(42)
+0%
|
(36)
+15%
|
(31)
+13%
|
(25)
+21%
|
(16)
+36%
|
(36)
-127%
|
0
N/A
|
(14)
N/A
|
(1)
+94%
|
31
N/A
|
37
+19%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(5)
|
(3)
|
(2)
|
1
|
2
|
3
|
2
|
1
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
1
|
0
|
0
|
(2)
|
(29)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(21)
N/A
|
(20)
+3%
|
(20)
-2%
|
(21)
-1%
|
(24)
-14%
|
(26)
-8%
|
(29)
-12%
|
(32)
-11%
|
(34)
-5%
|
(35)
-6%
|
(35)
+2%
|
(32)
+9%
|
(29)
+9%
|
(28)
+3%
|
(30)
-8%
|
(38)
-26%
|
(44)
-17%
|
(47)
-6%
|
(48)
-2%
|
(42)
+12%
|
(36)
+14%
|
(28)
+22%
|
(18)
+37%
|
(37)
-110%
|
(27)
+28%
|
(12)
+56%
|
1
N/A
|
33
+2 108%
|
36
+10%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
1
|
2
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(21)
|
(20)
|
(20)
|
(21)
|
(24)
|
(26)
|
(29)
|
(32)
|
(34)
|
(36)
|
(35)
|
(32)
|
(29)
|
(28)
|
(30)
|
(38)
|
(44)
|
(47)
|
(48)
|
(42)
|
(36)
|
(28)
|
(18)
|
(36)
|
(25)
|
(10)
|
3
|
33
|
35
|
|
Net Income (Common) |
(21)
N/A
|
(20)
+3%
|
(20)
-2%
|
(21)
-1%
|
(24)
-14%
|
(26)
-8%
|
(29)
-12%
|
(32)
-11%
|
(34)
-5%
|
(36)
-6%
|
(35)
+2%
|
(32)
+9%
|
(29)
+9%
|
(28)
+3%
|
(30)
-8%
|
(38)
-26%
|
(44)
-17%
|
(47)
-6%
|
(48)
-2%
|
(42)
+12%
|
(36)
+14%
|
(28)
+22%
|
(18)
+37%
|
(36)
-101%
|
(25)
+30%
|
(10)
+59%
|
3
N/A
|
33
+987%
|
35
+9%
|
|
EPS (Diluted) |
-1.03
N/A
|
-0.99
+4%
|
-1.01
-2%
|
-1.02
-1%
|
-1.17
-15%
|
-1.27
-9%
|
-1.36
-7%
|
-1.51
-11%
|
-2.36
-56%
|
-1.68
+29%
|
-1.49
+11%
|
-1.16
+22%
|
-1.16
N/A
|
-1.01
+13%
|
-1.1
-9%
|
-1.38
-25%
|
-1.6
-16%
|
-1.67
-4%
|
-1.72
-3%
|
-1.39
+19%
|
-1.23
+12%
|
-0.87
+29%
|
-0.54
+38%
|
-1.1
-104%
|
-0.77
+30%
|
-0.29
+62%
|
0.08
N/A
|
0.91
+1 038%
|
1.01
+11%
|